DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

References

Pavel ME. et al.
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study.

Lancet 2011;
378: 2005-2012

Download Bibliographical Data

Search in:
Access: